Works matching IS 00071188 AND DT 2014 AND VI 171 AND IP 19

Results: 18

Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370.
Published in:
2014
By:
- Jepps, T A;
- Bentzen, B H;
- Stott, J B;
- Povstyan, O V;
- Sivaloganathan, K;
- Dalby-Brown, W;
- Greenwood, I A
Publication type:
journal article
PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes.
Published in:
2014
By:
- Chien, Peter Tzu-Yu;
- Hsieh, Hsi-Lung;
- Chi, Pei-Ling;
- Yang, Chuen-Mao
Publication type:
journal article
CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR.
Published in:
2014
By:
- Wang, Yiting;
- Liu, Jia;
- Loizidou, Avgi;
- Bugeja, Luc A;
- Warner, Ross;
- Hawley, Bethan R;
- Cai, Zhiwei;
- Toye, Ashley M;
- Sheppard, David N;
- Li, Hongyu
Publication type:
journal article
Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels.
Published in:
2014
By:
- Cregg, R;
- Cox, J J;
- Bennett, D L H;
- Wood, J N;
- Werdehausen, R
Publication type:
journal article
Overexpression of oxytocin receptors in the hypothalamic PVN increases baroreceptor reflex sensitivity and buffers BP variability in conscious rats.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. 4385, doi. 10.1111/bph.12776
By:
- Lozić, Maja;
- Greenwood, Michael;
- Šarenac, Olivera;
- Martin, Andrew;
- Hindmarch, Charles;
- Tasić, Tatjana;
- Paton, Julian;
- Murphy, David;
- Japundžić ‐ Žigon, Nina
Publication type:
Article
CFTR potentiators partially restore channel function to A561 E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del- CFTR.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. 4490, doi. 10.1111/bph.12791
By:
- Wang, Yiting;
- Liu, Jia;
- Loizidou, Avgi;
- Bugeja, Luc A;
- Warner, Ross;
- Hawley, Bethan R;
- Cai, Zhiwei;
- Toye, Ashley M;
- Sheppard, David N;
- Li, Hongyu
Publication type:
Article
Pharmacological regulators of autophagy and their link with modulators of lupus disease.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. 4337, doi. 10.1111/bph.12792
By:
- Gros, Frédéric;
- Muller, Sylviane
Publication type:
Article
PAR1-dependent COX-2/ PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. 4504, doi. 10.1111/bph.12794
By:
- Chien, Peter Tzu ‐ Yu;
- Hsieh, Hsi ‐ Lung;
- Chi, Pei ‐ Ling;
- Yang, Chuen ‐ Mao
Publication type:
Article
Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. 4440, doi. 10.1111/bph.12795
By:
- Dong, Qinghua;
- Chen, Long;
- Lu, Qunwei;
- Sharma, Sherven;
- Li, Lei;
- Morimoto, Sachio;
- Wang, Guanyu
Publication type:
Article
Issue Information.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. i, doi. 10.1111/bph.12388
Publication type:
Article
Ulinastatin activates haem oxygenase 1 antioxidant pathway and attenuates allergic inflammation.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. 4399, doi. 10.1111/bph.12780
By:
- Song, Dongmei;
- Song, Geng;
- Niu, Yinghao;
- Song, Wei;
- Wang, Jiantao;
- Yu, Lei;
- Yang, Jianwang;
- Lv, Xin;
- Steinberg, Harry;
- Liu, Shu Fang;
- Wang, Baoshan
Publication type:
Article
Pharmacological bronchodilation is partially mediated by reduced airway wall stiffness.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. 4376, doi. 10.1111/bph.12781
By:
- Ansell, T K;
- Noble, P B;
- Mitchell, H W;
- McFawn, P K
Publication type:
Article
Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858 F NaV1.7 sodium channels.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. 4455, doi. 10.1111/bph.12788
By:
- Cregg, R;
- Cox, J J;
- Bennett, D L H;
- Wood, J N;
- Werdehausen, R
Publication type:
Article
Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. 4478, doi. 10.1111/bph.12800
By:
- Wang, Minghua;
- Shim, Joong Sup;
- Li, Ruo ‐ Jing;
- Dang, Yongjun;
- He, Qingli;
- Das, Manisha;
- Liu, Jun O
Publication type:
Article
Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. 4464, doi. 10.1111/bph.12803
By:
- Murase, Ryuichi;
- Kawamura, Rumi;
- Singer, Eric;
- Pakdel, Arash;
- Sarma, Pranamee;
- Judkins, Jonathon;
- Elwakeel, Eiman;
- Dayal, Sonali;
- Martinez ‐ Martinez, Esther;
- Amere, Mukkanti;
- Gujjar, Ramesh;
- Mahadevan, Anu;
- Desprez, Pierre ‐ Yves;
- McAllister, Sean D
Publication type:
Article
Vasorelaxant effects of novel Kv7.4 channel enhancers ML213 and NS15370.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. 4413, doi. 10.1111/bph.12805
By:
- Jepps, T A;
- Bentzen, B H;
- Stott, J B;
- Povstyan, O V;
- Sivaloganathan, K;
- Dalby ‐ Brown, W;
- Greenwood, I A
Publication type:
Article
Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. 4425, doi. 10.1111/bph.12808
By:
- Neveu, C;
- Dulin, F;
- Lefranc, B;
- Galas, L;
- Calbrix, C;
- Bureau, R;
- Rault, S;
- Chuquet, J;
- Boutin, J A;
- Guilhaudis, L;
- Ségalas ‐ Milazzo, I;
- Vaudry, D;
- Vaudry, H;
- Santos, J Sopkova ‐ de Oliveira;
- Leprince, J
Publication type:
Article
Purinergic neuromuscular transmission in the gastrointestinal tract; functional basis for future clinical and pharmacological studies.
Published in:
British Journal of Pharmacology, 2014, v. 171, n. 19, p. 4360, doi. 10.1111/bph.12802
By:
- Jiménez, Marcel;
- Clavé, Pere;
- Accarino, Anna;
- Gallego, Diana
Publication type:
Article

Works matching IS 00071188 AND DT 2014 AND VI 171 AND IP 19

Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370.

PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes.

CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR.

Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels.

Overexpression of oxytocin receptors in the hypothalamic PVN increases baroreceptor reflex sensitivity and buffers BP variability in conscious rats.

CFTR potentiators partially restore channel function to A561 E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del- CFTR.

Pharmacological regulators of autophagy and their link with modulators of lupus disease.

PAR1-dependent COX-2/ PGE<sub>2</sub> production contributes to cell proliferation via EP<sub>2</sub> receptors in primary human cardiomyocytes.

Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression.

Issue Information.

Ulinastatin activates haem oxygenase 1 antioxidant pathway and attenuates allergic inflammation.

Pharmacological bronchodilation is partially mediated by reduced airway wall stiffness.

Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858 F Na<sub>V</sub>1.7 sodium channels.

Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer.

Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.

Vasorelaxant effects of novel K<sub>v</sub>7.4 channel enhancers ML213 and NS15370.

Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies.

Purinergic neuromuscular transmission in the gastrointestinal tract; functional basis for future clinical and pharmacological studies.